Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
E-3810-I-01 : Essai de phase 1, visant à déterminer la dose maximale tolérée, la dose recommandée, la pharmacocinétique et la pharmacodynamique de l’E-3810, un inhibiteur de VEGFR-FGFR, chez des patients ayant une tumeur solide avancée. [essai clos aux inclusions] https://kusajili.com:443/Trial/jvZLx7XwKE-Ym_xTLiTZPA%24e-3810-i-01-essai-de-phase-1-visant-a-determiner-la-dose-maximale-toleree-la-dose-recommandee-la-pharmacocinetique-et-la-pharma
I have read and accept the terms of use of the site and the Privacy Policy
Send your message